Following on promising mice-based research that indicated THC might provide effective protection from acute respiratory distress syndrome (ARDS), Ottawa, Canada-based Tetra Bio-Pharma has received FDA approval for Phase 1 testing of its synthetic cannabinoid drug, ARDS-003. ARDS is a severe lung injury that leads to significant morbidity and mortality, especially in older people, and the [\u2026]<\/p>\n
Ottawa, Canada, firm gains FDA approval to test potential COVID-19 drug<\/a> is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs<\/a><\/p>\n
Following on promising mice-based research that indicated THC might provide effective protection from acute respiratory distress syndrome (ARDS), Ottawa, Canada-based Tetra Bio-Pharma has received FDA approval for Phase 1 testing of its synthetic cannabinoid drug, ARDS-003. ARDS is a severe lung injury that leads to significant morbidity and mortality, especiallyContinue Reading<\/a><\/span><\/p>\n","protected":false},"author":400,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[14035,14018,13218,13342],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/44475"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/400"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=44475"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/44475\/revisions"}],"predecessor-version":[{"id":44476,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/44475\/revisions\/44476"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=44475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=44475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=44475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n
\nRead More: Ottawa, Canada, firm gains FDA approval to test potential COVID-19 drug<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"